Ofori-Adjei, D.Dodoo, A.N.Fogg, C.Asiimwe, A.Nartey, E.T.Kodua, A.Tenkorang, O.2018-09-252018-09-252009http://ugspace.ug.edu.gh/handle/123456789/24340ArticleChange of first-line treatment of uncomplicated malaria to artemisinin-combination therapy (ACT) is widespread in Africa. To expand knowledge of safety profiles of ACT, pharmacovigilance activities are included in the implementation process of therapy changes. Ghana implemented first-line therapy of artesunate-amodiaquine in 2005. Drug utilization data is an important component of determining drug safety, and this paper describes how anti-malarials were prescribed within a prospective pharmacovigilance study in Ghana following anti-malarial treatment policy change.enDrug UtilizationTreatmentArtemisinin-Combination TherapyArticle